Systemic zinc protoporphyrin administration reduces intracerebral hemorrhage-induced brain injury

Acta Neurochirurgica, Supplementum

Volumn , Issue 96, 2006, Pages 232-236

  Gong, Y ^a,b   Tian, H ^a   Xi, G ^a   Keep, R F ^a   Hoff, J T ^a   Hua, Y ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b FUDAN UNIVERSITY   (China)

Author keywords

heme oxygenase inhibitor; Intracerebral hemorrhage; zinc protoporphyrin

Indexed keywords

HEME OXYGENASE; NEUROPROTECTIVE AGENT;

ANIMAL; ARTICLE; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INJURY; DISEASE MODEL; DRUG ANTAGONISM; INFUSION; MALE; MENTAL DISEASE; RAT; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; BRAIN EDEMA; BRAIN INJURIES; CEREBRAL HEMORRHAGE; DISEASE MODELS, ANIMAL; HEME OXYGENASE (DECYCLIZING); INFUSIONS, PARENTERAL; MALE; MENTAL DISORDERS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 85052609611     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/3-211-30714-1_50     Document Type: Article

References (16)

1. Felberg RA, Grotta JC, Shirzadi AL, Strong R, Narayana P, Hill-Felberg SJ, Aronowski J (2002) Cell death in experimental intracerebral hemorrhage: the "black hole" model of hemorrhagic damage. Ann Neurol 51:517-524
2. Grundemar L, Ny L (1997) Pitfalls using metalloporphyrins in carbon monoxide research. Trends Pharmacol Sci 18:193-195
3. Hua Y, Schallert T, Keep RF, Wu J, Hoff JT, Xi G (2002) Behavioral tests after intracerebral hemorrhage in the rat. Stroke 33:2478-2484
4. Huang F, Xi G, Keep RF, Hua Y, Nemoianu A, Hoff JT (2002) Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J Neurosurg 96:287-293
5. Koeppen AH, Dickson AC, Smith J (2004) Heme oxygenase in experimental intracerebral hemorrhage: the benefit of tinmesoporphyrin. J Neuropathol Exp Neurol 63:587-597
6. Kutty RK, Maines MD (1981) Purification and characterization of biliverdin reductase from rat liver. J Biol Chem 256:3956-3962
7. Nakamura T, Keep R, Hua Y, Schallert T, Hoff J, Xi G (2004) Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J Neurosurg 100:672-678
8. Schallert T, Upchurch M, Wilcox RE, Vaughn DM (1983) Posture-independent sensorimotor analysis of inter-hemispheric receptor asymmetries in neostriatum. Pharmacol Biochem Behav 18:753-759
9. Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST (2000) CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39:777-787
10. Skriver EB, Olsen TS (1986) Tissue damage at computed tomography following resolution of intracerebral hematomas. Acta Radiol Diag (Stockh) 27:495-500
11. Wagner KR, Hua Y, de Courten-Myers GM, Broderick JP, Nishimura RN, Lu SY, Dwyer BE (2000) Tin-mesoporphyrin, a potent heme oxygenase inhibitor, for treatment of intracerebral hemorrhage: in vivo and in vitro studies. Cell Mol Biol (Noisy-le-grand) 46:597-608
12. Wu J, Hua Y, Keep RF, Schallert T, Hoff JT, Xi G (2002) Oxidative brain injury from extravasated erythrocytes after intracerebral hemorrhage. Brain Res 953:45-52
13. Wu J, Hua Y, Keep RF, Nakamura T, Hoff JT, Xi G (2003) Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke 34:2964-29696
14. Xi G, Keep RF, Hoff JT (1998) Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. J Neurosurg 89:991-996
15. Xi G, Fewel ME, Hua Y, Thompson BG, Hoff J, Keep R (2004) Intracerebral hemorrhage: pathophysiology and therapy. Neurocrit Care 1:5-18
16. Zazulia AR, Diringer MN, Derdeyn CP, Powers WJ (1999) Progression of mass effect after intracerebral hemorrhage. Stroke 30:1167-1173